You are here

A multi-ethnic polygenic risk score is associated with hypertension prevalence and progression throughout adulthood.

TitleA multi-ethnic polygenic risk score is associated with hypertension prevalence and progression throughout adulthood.
Publication TypeJournal Article
Year of Publication2022
AuthorsKurniansyah, N, Goodman, MO, Kelly, TN, Elfassy, T, Wiggins, KL, Bis, JC, Guo, X, Palmas, W, Taylor, KD, Lin, HJ, Haessler, J, Gao, Y, Shimbo, D, Smith, JA, Yu, B, Feofanova, EV, Smit, RAJ, Wang, Z, Hwang, S-J, Liu, S, Wassertheil-Smoller, S, Manson, JAE, Lloyd-Jones, DM, Rich, SS, Loos, RJF, Redline, S, Correa, A, Kooperberg, C, Fornage, M, Kaplan, RC, Psaty, BM, Rotter, JI, Arnett, DK, Morrison, AC, Franceschini, N, Levy, D, Sofer, T
Corporate/Institutional AuthorsNHLBI Trans-Omics in Precision Medicine (TOPMed) Consortium
JournalNat Commun
Volume13
Issue1
Pagination3549
Date Published2022 Jun 21
ISSN2041-1723
KeywordsAdult, Diabetes Mellitus, Type 2, Genetic Predisposition to Disease, Genome-Wide Association Study, Humans, Hypertension, Multifactorial Inheritance, Prevalence, Risk Factors
Abstract<p>In a multi-stage analysis of 52,436 individuals aged 17-90 across diverse cohorts and biobanks, we train, test, and evaluate a polygenic risk score (PRS) for hypertension risk and progression. The PRS is trained using genome-wide association studies (GWAS) for systolic, diastolic blood pressure, and hypertension, respectively. For each trait, PRS is selected by optimizing the coefficient of variation (CV) across estimated effect sizes from multiple potential PRS using the same GWAS, after which the 3 trait-specific PRSs are combined via an unweighted sum called "PRSsum", forming the HTN-PRS. The HTN-PRS is associated with both prevalent and incident hypertension at 4-6 years of follow up. This association is further confirmed in age-stratified analysis. In an independent biobank of 40,201 individuals, the HTN-PRS is confirmed to be predictive of increased risk for coronary artery disease, ischemic stroke, type 2 diabetes, and chronic kidney disease.</p>
DOI10.1038/s41467-022-31080-2
Alternate JournalNat Commun
PubMed ID35729114
PubMed Central IDPMC9213527
ePub date: 
22/06